7J3-18093-10246
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 337 / FL
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Registered in v-safe
- 2021-04-16
- 2021-04-19
- 2021-04-28
-
2021-05-03
Dose 2 — Pfizer-BioNTech
- 2021-05-03
-
2021-05-04
Survey response — days 1–6 daily, dose 2MedDRA: Sneezing — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: SneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-06
- 2021-05-07
- 2021-05-08
- 2021-05-10
-
2021-05-17
Survey response — day 14, dose 2MedDRA: Fatigue, Headache, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Nausea, headache, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-24
- 2021-05-31
- 2021-06-02
-
2021-06-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-06-09
- 2021-06-16
- 2021-08-04
- 2021-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-17 | Successful 2021-06-03 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Sneezing
Release 8 — day 14, dose 2
Symptoms: Nausea, headache, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release